CONTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 6.861
AS - Asia 4.882
EU - Europa 4.323
SA - Sud America 540
AF - Africa 109
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.762
Nazione #
US - Stati Uniti d'America 6.637
CN - Cina 1.687
SG - Singapore 1.618
IT - Italia 1.490
DE - Germania 443
VN - Vietnam 441
BR - Brasile 402
SE - Svezia 388
FR - Francia 364
IE - Irlanda 313
FI - Finlandia 267
KR - Corea 210
JP - Giappone 156
GB - Regno Unito 151
IN - India 151
UA - Ucraina 149
HK - Hong Kong 146
DK - Danimarca 133
AT - Austria 132
PL - Polonia 122
CA - Canada 110
MX - Messico 79
ID - Indonesia 77
NL - Olanda 64
TR - Turchia 63
BE - Belgio 55
IQ - Iraq 54
RU - Federazione Russa 54
IR - Iran 51
AR - Argentina 48
ES - Italia 41
AU - Australia 39
SN - Senegal 39
TW - Taiwan 34
BD - Bangladesh 32
EC - Ecuador 23
PT - Portogallo 23
GR - Grecia 22
PK - Pakistan 22
CL - Cile 20
CZ - Repubblica Ceca 18
ZA - Sudafrica 18
CH - Svizzera 17
EG - Egitto 15
HU - Ungheria 15
MY - Malesia 15
CO - Colombia 14
TH - Thailandia 13
VE - Venezuela 13
SA - Arabia Saudita 12
IL - Israele 10
NO - Norvegia 10
PE - Perù 10
RO - Romania 10
UZ - Uzbekistan 10
JO - Giordania 9
PH - Filippine 9
CU - Cuba 8
LB - Libano 8
LT - Lituania 8
MO - Macao, regione amministrativa speciale della Cina 7
PY - Paraguay 7
CR - Costa Rica 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
BY - Bielorussia 5
CY - Cipro 5
DZ - Algeria 5
JM - Giamaica 5
KE - Kenya 5
NP - Nepal 5
SY - Repubblica araba siriana 5
BG - Bulgaria 4
ET - Etiopia 4
EU - Europa 4
MA - Marocco 4
MD - Moldavia 4
NG - Nigeria 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
NZ - Nuova Zelanda 3
AL - Albania 2
BH - Bahrain 2
BN - Brunei Darussalam 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
ML - Mali 2
MN - Mongolia 2
PR - Porto Rico 2
Totale 16.738
Città #
Singapore 950
Chandler 611
San Jose 591
Ashburn 552
Beijing 485
Fairfield 371
Turin 348
Torino 332
Dublin 310
Houston 263
Santa Clara 256
Ann Arbor 196
Wilmington 187
Cambridge 168
Woodbridge 163
The Dalles 133
Seattle 130
Nyköping 115
Vienna 110
Ho Chi Minh City 108
Dearborn 106
Hanoi 100
Hong Kong 100
Milan 100
Munich 99
Warsaw 96
Dallas 94
Los Angeles 93
Helsinki 92
Villeurbanne 92
Columbus 91
Jacksonville 90
Lauterbourg 90
Seoul 89
Shanghai 88
Princeton 86
Medford 85
Redwood City 80
Pisa 77
Guangzhou 75
Hefei 75
Tokyo 63
Buffalo 57
Jakarta 57
Nanjing 56
Hangzhou 55
New York 50
São Paulo 50
Frankfurt am Main 49
Turku 47
Boston 42
Dong Ket 41
Nuremberg 39
Council Bluffs 37
Washington 37
Boardman 34
Chengdu 34
Brussels 32
Orem 32
Chennai 31
Rome 31
Wuhan 30
Fremont 29
Zhengzhou 28
Changsha 27
Silver Spring 27
Xian 25
Ottawa 24
San Diego 24
Taipei 23
Phoenix 22
Amsterdam 21
Bengaluru 21
Baghdad 20
Istanbul 20
Jinan 20
London 20
Paris 20
Chongqing 19
Lappeenranta 19
Shenyang 19
Toronto 19
Brooklyn 18
Hyderabad 18
Padova 18
Redondo Beach 18
Tianjin 18
Stockholm 17
Ankara 16
Chicago 16
Da Nang 16
Kunming 16
Montreal 16
Rio de Janeiro 16
Atlanta 15
Düsseldorf 15
Mexico City 15
Haiphong 13
Parma 13
Verona 12
Totale 9.914
Nome #
Breast cancer stem cell antigens as targets for immunotherapy 1.101
Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells 507
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 499
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging 438
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 351
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 348
NK cells control breast cancer and related cancer stem cell hematological spread 346
Multi-level model for the investigation of oncoantigen- driven vaccination effect 301
A mathematical-biological joint effort to investigate the tumor-initiating ability of cancer stem cells. 301
Cancer stem cell antigens as targets for new combined anti-cancer therapies 297
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 277
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 272
RNAs competing for microRNAs mutually influence their fluctuations in a highly non-linear microRNA-dependent manner in single cells 269
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 263
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 249
The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy 242
Targeting the extracellular HSP90 co-chaperone Morgana inhibits cancer cell migration and promotes anti-cancer immunity 232
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells 227
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 226
The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis 216
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 216
L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents 215
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 206
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential 201
Water Soluble Melanin Derivatives for Dynamic Contrast Enhanced Photoacoustic Imaging of Tumor Vasculature and Response to Antiangiogenic Therapy 197
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota 197
B7h triggering inhibits the migration of tumor cell lines. 196
In Human Multiple sclerosis, T helper 17 lymphocytes display increased levels of JAK2 that stabilize cell surface IFN-YR2chain 195
Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice 192
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 184
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 183
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 180
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 179
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 172
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 171
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 171
Cripto-1 Plasmid DNA Vaccination Targets Metastasis and Cancer Stem Cells in Murine Mammary Carcinoma 171
Multi-level model for the investigation of oncoantigen-driven vaccination effect 160
Cancer Stem Cell based adjuvant for oncoantingen-driven vaccination 160
Multiple Roles of Perforin in Hampering ERBB-2 (Her-2/neu) Carcinogenesis in Transgenic Male Mice 157
B7H triggering inhibits migration of tumor cell lines 157
Liver-Specific siRNA-Mediated Stat3 or C3 Knockdown Improves the Outcome of Experimental Autoimmune Myocarditis 156
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 155
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 153
Iron regulates T-lymphocyte sensitivity to the IFN-gamma/STAT1 signaling pathway in vitro and in vivo. 151
Tissue memory relies on stem cell priming in distal undamaged areas 150
B7h triggering inhibits the migration of tumor cell lines x 147
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models 145
T helper 17 cells expand in multiple sclerosis and are inhibited by interferon-β 144
A new optical imaging probe targeting α(V) β(3) integrin in glioblastoma xenografts. 136
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytes 133
TYPE 1 INTERFERON RECEPTOR (IFNA-R1). EXPRESSING TH17 LYMPHOCYTES ARE INCREASED DURING MS RELAPSES AND ARE SELECTIVELY INTHBITED BY IFNβ 131
In the absence of IGF-1 signaling, IFN-gamma suppresses human malignant T-cell growth 131
Iron regulates T lymphocyte sensitivity to the IFN-g/STAT1 signaling pathway in vitro and in vivo 131
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer 129
Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy? 128
A Magnetic Resonance Imaging‐Chemical Exchange Saturation Transfer (MRI‐CEST) Method for the Detection of Water Cycling across Cellular Membranes 127
Retrovirus-mediated targeting of the Insulin-like Growth Factor-1 Receptor reinstates T lymphocytes sensitivity to the apoptotic effect of IFN-g 124
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 124
Th17, an effector T Lymphocyte subset associated with multiple sclerosis (MS) relapses: antigen specificity, cytokine production, and sensitivity to interferon beta 123
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy 122
Flow Cytometry for Beginners: Hints and Tips for Approaching the Very First Single-Cell Technique 119
A Novel PSMA-Targeted Probe for NIRF-Guided Surgery and Photodynamic Therapy: Synthesis and Preclinical Validation 118
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 118
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment 116
T-helper 17 lymphocytes increase during multiple sclerosis relapses and are inhibited by interferon beta 116
In T lymphocytes, ablation of STAT3 expression reinstates STAT1-dependent apoptosis by both IFNg and IL-6 115
T helper 17 Lymphocytes and multiple sclerosis: their increase in active phases of disease and the interferon beta induced inhibition 114
T-helper 17 lymphocytes during MS relapses: antigen specificity and cytokine production. A multicentre longitunal study 113
In the absence of Insulin-like Growth Factor (IGF)-1 signaling, Interferon-gamma (IFN-g) inhibits the growth of human malignant T cells 109
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 109
Optical imaging detection of microscopic mammary cancer in ErbB-2 transgenic mice through the DA364 probe bindingαvβ3integrins 107
The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy 106
Cancer vaccines: Target antigens, vaccine platforms and preclinical models 104
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 101
Th17 lymphocytes are expandend in multiple sclerosis and are inhibited by interferon beta 101
Iron chelation restores human T cells sensitivity to the IFN-g/STAT1 signaling pathway. Jaks and Stats: development to disease 100
IL- 17 and IL-22 producing increased in multiple sclerosis relapses are MBP-specific. A multi-centre longitudinal study 99
Effect of Mitoquinone on sperm quality of cryopreserved stallion semen 98
Ready for a new saga? Th17 and not Th1 are selectively increased in active multiple sclerosis and undergo apoptosis with interferon beta 95
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 94
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 93
T-helper 17 lymphocytes during MS relapses: antigen specifity and cytokine production. A multicentre longitudinal sudy 90
IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing 89
Th17 Cells in Multiple Sclerosis Express Higher Levels of JAK2, Which Increases Their Surface Expression of IFN-γR2 89
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine 85
Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model. 84
JAK2 is overexpressed in human multiple sclerosis Th17 cells andstabilizes cell surface expression of IFN-gammaR2. 82
MBP-Specific Th17 Lymphocytes selectively increase during MS relapses. A multicenter longitudinal Study 79
Interleukin-17 t lymphocyte production correlates with disease activity in Multiple Sclerosis 78
Longitudinal analysis of IL-17 and/or IL-22 producing CD4+ T lymphocytes in relapsing remitting multiple sclerosis 78
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 77
Ready for a new saga? Th17 and not Th1 are selectivly increate in active multiple sclerosis and undergo apoptosis with interferon beta 76
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern 75
JAK2 is overexpressed in human multiple sclerosis Th17 cells and stabilizes cell surface expression of IFN-gammaR2 75
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? 73
The noninflammatory role of high mobility group box 1/toll-like receptor 2 axis in the self-renewal of mammary cancer stem cells 71
Modulation of STAT1 signaling pathway by Interferons (IFNs) in human T helper (Th)17 lymphocytes 61
Novel FAP-Targeted Heptamethine Cyanines for NIRF Imaging Applications 43
In situ sonoporation to enhance the tumour uptake of silicon phthalocyanine and improve PDT effectiveness in a triple negative breast cancer murine model 28
Totale 17.140
Categoria #
all - tutte 47.250
article - articoli 0
book - libri 0
conference - conferenze 8.683
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021321 0 0 0 0 0 0 0 0 0 0 133 188
2021/20221.651 100 93 82 155 109 111 110 102 79 183 267 260
2022/20231.918 195 146 53 187 139 458 155 145 179 49 134 78
2023/20241.244 130 153 108 87 114 129 93 88 18 95 113 116
2024/20252.714 71 116 144 229 497 260 140 156 326 168 226 381
2025/20264.734 486 247 331 567 600 260 917 242 427 555 102 0
Totale 17.188